New York State Common Retirement Fund Travere Therapeutics, Inc. Transaction History
New York State Common Retirement Fund
- $74.6 Billion
- Q4 2024
A detailed history of New York State Common Retirement Fund transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 22,914 shares of TVTX stock, worth $463,321. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,914
Previous 22,914
-0.0%
Holding current value
$463,321
Previous $321,000
24.3%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding TVTX
# of Institutions
198Shares Held
84.9MCall Options Held
776KPut Options Held
912K-
Armistice Capital, LLC New York, NY7.65MShares$155 Million1.78% of portfolio
-
Black Rock Inc. New York, NY7.64MShares$155 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.9MShares$140 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.68MShares$94.7 Million2.23% of portfolio
-
Woodline Partners LP San Francisco, CA4.34MShares$87.8 Million0.55% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.3B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...